Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ · Healthcare
Cumberland Pharmaceuticals Inc. Operating Income 2009–2025
Cumberland Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cumberland Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -3.1 M, a 342.22% decrease year-over-year.
- Cumberland Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -4.6 M, a 29.53% decrease year-over-year.
- Cumberland Pharmaceuticals Inc. annual operating income for 2025 was -2.8 M, a 56.59% decrease from 2024.
- Cumberland Pharmaceuticals Inc. annual operating income for 2024 was -6.4 M, a 32.68% decrease from 2023.
- Cumberland Pharmaceuticals Inc. annual operating income for 2023 was -9.6 M, a 67.48% increase from 2022.
- Cumberland Pharmaceuticals Inc. annual operating income for 2022 was -5.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cumberland Pharmaceuticals Inc. Operating Income — FAQ
Cumberland Pharmaceuticals Inc. (CPIX) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Cumberland Pharmaceuticals Inc.'s operating income?
Cumberland Pharmaceuticals Inc. (CPIX) reported operating income of -$3M for fiscal 2025.
Where can I see CPIX's operating income history?
The chart and table above show Cumberland Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.